drugset / Trial / NCT04582786

Dose Finding Study of STR-324

NCT04582786

Phase 2 Unknown 118 enrolled Alaxia SAS
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to evaluate the analgesic effect and the safety of 4 doses of STR-324 administered as an infusion, with or without initial bolus, to patients suffering from post-operative pain. The sensitivity of the pain model used in the trial will be evaluated with a standard group treated with morphine under the usual care conditions.

Timeline

Start
2020-12-01
Primary completion
2022-01
Completion
2022-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified Intravenous
Subject STR-324 Unknown Intravenous

Indications

No indication recorded.